Organ transplantation and parasitic infection

Ye Junsheng

doi:10.3969/j.issn.1674-7445.2022.04.005

Volume 13 Issue 4

Jul. 2022

Turn off MathJax

Article Contents

Article Navigation > ORGAN TRANSPLANTATION > 2022 > 13(4): 440-447

Ye Junsheng. Organ transplantation and parasitic infection[J]. ORGAN TRANSPLANTATION, 2022, 13(4): 440-447. doi: 10.3969/j.issn.1674-7445.2022.04.005

Citation:

Ye Junsheng. Organ transplantation and parasitic infection[J]. ORGAN TRANSPLANTATION, 2022, 13(4): 440-447. doi: 10.3969/j.issn.1674-7445.2022.04.005

Citation:

Ye Junsheng. Organ transplantation and parasitic infection[J]. ORGAN TRANSPLANTATION, 2022, 13(4): 440-447. doi: 10.3969/j.issn.1674-7445.2022.04.005

PDF( 8351 KB)

Organ transplantation and parasitic infection

doi: 10.3969/j.issn.1674-7445.2022.04.005

Ye Junsheng^,

Department of Kidney Transplantation, Beijing Tsinghua Changgung Hospital affiliated to Tsinghua University, Beijjng 102218, China

More Information

Corresponding author: Ye Junsheng, Email: yejunsh@126.com
Received Date: 2022-03-29
Available Online: 2022-07-14
Publish Date: 2022-07-15

Abstract

Abstract

Parasitic infection is manifested with the characteristics of both endemic and infectious diseases, and the onset of parasitic infection is regional and infectious. The incidence of parasitic infection after organ transplantation is relatively low, primarily occurring in single case or case series in developing countries and regions. With the development of social economy and a gradual increasing number of organ transplantation, the risk of parasitic exposure is increased when the recipients travel among different countries or regions. In addition, immunosuppression is the risk factor of parasitic infection. Consequently, the risk of parasitic infection in organ transplant recipients cannot be ignored. In this article, epidemiological characteristics, clinical manifestations, diagnosis, treatment and prevention of parasitic infection after organ transplantation were classified and summarized according to literature review, aiming to provide reference for the prevention and treatment of parasitic infection in organ transplant recipients.
- Parasite,
- Host,
- Organ transplantation,
- Donor-derived infection,
- Immunosuppressive treatment,
- Latent infection,
- Polymerase chain reaction (PCR),
- Enzyme-linked immune absorbent assay (ELISA)

FullText(HTML)

References(36)

References

[1]	孙雁, 于立新. 原位肝移植术后弓形虫脑炎一例[J]. 中华器官移植杂志, 2018, 39(8): 499-501. DOI: 10.3760/cma.j.issn.0254-1785.2018.08.013. SUN Y, YU LX. A case of toxoplasma encephalitis after orthotopic liver transplantation[J]. Chin J Organ Transplant, 2018, 39(8): 499-501. DOI: 10.3760/cma.j.issn.0254-1785.2018.08.013.
[2]	RAMANAN P, SCHERGER S, BENAMU E, et al. Toxoplasmosis in non-cardiac solid organ transplant recipients: a case series and review of literature[J]. Transpl Infect Dis, 2020, 22(1): e13218. DOI: 10.1111/tid.13218.
[3]	FERNÀNDEZ-SABÉ N, CERVERA C, FARIÑAS MC, et al. Risk factors, clinical features, and outcomes of toxoplasmosis in solid-organ transplant recipients: a matched case-control study[J]. Clin Infect Dis, 2012, 54(3): 355-361. DOI: 10.1093/cid/cir806.
[4]	RAHIMI ESBOEI B, FALLAHI S, ZAREI M, et al. Utility of blood as the clinical specimen for the diagnosis of ocular toxoplasmosis using uracil DNA glycosylase-supplemented loop-mediated isothermal amplification and real-time polymerase chain reaction assays based on REP-529 sequence and B1 gene[J]. BMC Infect Dis, 2022, 22(1): 89. DOI: 10.1186/s12879-022-07073-3.
[5]	MESQUITA RT, ZIEGLER ÂP, HIRAMOTO RM, et al. Real-time quantitative PCR in cerebral toxoplasmosis diagnosis of Brazilian human immunodeficiency virus-infected patients[J]. J Med Microbiol, 2010, 59(Pt 6): 641-647. DOI: 10.1099/jmm.0.016261-0.
[6]	DARD C, MARTY P, BRENIER-PINCHART MP, et al. Management of toxoplasmosis in transplant recipients: an update[J]. Expert Rev Anti Infect Ther, 2018, 16(6): 447-460. DOI: 10.1080/14787210.2018.1483721.
[7]	MARQUES N, BUSTORFF M, CORDEIRO DA SILVA A, et al. Visceral dissemination of mucocutaneous leishmaniasis in a kidney transplant recipient[J]. Pathogens, 2020, 10(1): 18. DOI: 10.3390/pathogens10010018.
[8]	DHALIWAL A, CHAUHAN A, AGGARWAL D, et al. Donor acquired visceral leishmaniasis following liver transplantation[J]. Frontline Gastroenterol, 2021, 12(7): 690-694. DOI: 10.1136/flgastro-2020-101659.
[9]	DE OLIVEIRA FRANÇA A, DA CUNHA GMR, OLIVEIRA LP, et al. Presence of anti-leishmania antibodies in candidates for kidney transplantation[J]. Int J Infect Dis, 2020, 98: 470-477. DOI: 10.1016/j.ijid.2020.07.006.
[10]	《中华传染病杂志》编辑委员会. 中国利什曼原虫感染诊断和治疗专家共识[J]. 中华传染病杂志, 2017, 35(9): 513-518. DOI: 10.3760/cma.j.issn.1000-6680.2017.10.001. Editorial Board of Chinese Journal of Infectious Diseases. Expert consensus on diagnosis and treatment of leishmania infection in China[J]. Chin J Infect Dis, 2017, 35(9): 513-518. DOI: 10.3760/cma.j.issn.1000-6680.2017.10.001.
[11]	POSTORINO MC, BELLANTONI M, CATALANO C, et al. Visceral leishmaniasis reactivation in transplant patients: a minireview with report of a new case[J]. J Nephrol, 2011, 24(4): 530-534. DOI: 10.5301/JN.2011.8343.
[12]	ROSSO F, AGUDELO ROJAS OL, SUAREZ GIL CC, et al. Transmission of malaria from donors to solid organ transplant recipients: a case report and literature review[J]. Transpl Infect Dis, 2021, 23(4): e13660. DOI: 10.1111/tid.13660.
[13]	WHO. World malaria report 2021[EB/OL]. [2022-01-26]. https://www.who.int/teams/global-malaria-programme/reports/world-malaria-report-2021.
[14]	蒙俏俊. 疟疾诊断技术进展与应用[J]. 中国医药科学, 2019, 9(1): 34-37, 43. DOI: 10.3969/j.issn.2095-0616.2019.01.009. MENG QJ. Progress and application of malaria diagnosis technology[J]. Chin Med Pharm, 2019, 9(1): 34-37, 43. DOI: 10.3969/j.issn.2095-0616.2019.01.009.
[15]	王婧婷, 关洪鑫, 张丹丹, 等. 抗疟疾药物研究进展[J]. 福建师范大学学报(自然科学版), 2022, 38(1): 103-116. DOI: 10.12046/j.issn.1000-5277.2022.01.013. WANG JT, GUAN HX, ZHANG DD, et al. Research progress on novel antimalarial drugs[J]. J Fujian Normal Univ(Nat Sci Edit), 2022, 38(1): 103-116. DOI: 10.12046/j.issn.1000-5277.2022.01.013.
[16]	PIERROTTI LC, LEVI ME, DI SANTI SM, et al. Malaria disease recommendations for solid organ transplant recipients and donors[J]. Transplantation, 2018, 102(2S Suppl 2): S16-S26. DOI: 10.1097/TP.0000000000002017.
[17]	ROSENBLATT J, LEUNG A, BANEMAN E, et al. Relapsed babesia microti infection following allogeneic hematopoietic cell transplantation in a patient with B-cell acute lymphoblastic leukemia: case report and review of the literature[J]. Open Forum Infect Dis, 2021, 8(9): ofab323. DOI: 10.1093/ofid/ofab323.
[18]	PURI A, BAJPAI S, MEREDITH S, et al. Babesia microti: pathogen genomics, genetic variability, immunodominant antigens, and pathogenesis[J]. Front Microbiol, 2021, 12: 697669. DOI: 10.3389/fmicb.2021.697669.
[19]	王鹤, 齐文杰. 北京地区人巴贝虫感染者一例[J/CD]. 中华实验和临床感染病杂志(电子版), 2019, 13(6): 519-523. DOI: 10.3877/cma.j.issn.1674-1358.2019.06.012. WANG H, QI WJ. A case report of human babesia infection in Beijing[J/CD]. Chin J Exp Clin Infect Dis(Electr Vers), 2019, 13(6): 519-523. DOI: 10.3877/cma.j.issn.1674-1358.2019.06.012.
[20]	袁冬娟, 姜虹, 肖蓓蕾, 等. 狒狒巴拉姆希阿米巴合并人疱疹病毒6A脑炎一例[J]. 脑与神经疾病杂志, 2020, 28(6): 345-349. https://www.cnki.com.cn/Article/CJFDTOTAL-LYSJ202006005.htm YUAN DJ, JIANG H, XIAO BL, et al. Balamuthia mandrillaris combined with human herpes virus 6A encephalitis[J]. J Brain Nerv Dis, 2020, 28(6): 345-349. https://www.cnki.com.cn/Article/CJFDTOTAL-LYSJ202006005.htm
[21]	王雷, 高天文. 从外伤后细菌性致死性肉芽肿到巴拉姆希阿米巴感染: 20年研究体会[J]. 中华皮肤科杂志, 2022, 55(2): 172-176. DOI: 10.35541/cjd.20201076. WANG L, GAO TW. From fatal bacterial granuloma after trauma to balamuthia mandrillaris infection: clinical experience over 20 years[J]. Chin J Dermatol, 2022, 55(2): 172-176. DOI: 10.35541/cjd.20201076.
[22]	FARNON EC, KOKKO KE, BUDGE PJ, et al. Transmission of balamuthia mandrillaris by organ transplantation[J]. Clin Infect Dis, 2016, 63(7): 878-888. DOI: 10.1093/cid/ciw422.
[23]	BHOSALE NK, PARIJA SC. Balamuthia mandrillaris: an opportunistic, free-living ameba - an updated review[J]. Trop Parasitol, 2021, 11(2): 78-88. DOI: 10.4103/tp.tp_36_21.
[24]	CHUNG SJ, STRAND AM, DIBERNARDO LR, et al. Confusion, headache, and constitutional symptoms in a heart transplant recipient[J]. Clin Infect Dis, 2019, 68(11): 1968-1973. DOI: 10.1093/cid/ciy519.
[25]	KUTNER A, ALDRICH M, PATEL S, et al. Acanthamoeba endophthalmitis during treatment for cutaneous disease in a renal transplant patient[J]. Transpl Infect Dis, 2018, 20(2): e12843. DOI: 10.1111/tid.12843.
[26]	GUIRGUIS D, KASHAT L, MORADI S, et al. An unusual source of sinonasal disease in an immunocompromised patient: a case report of the clinical presentation, diagnosis, and treatment of acanthamoeba rhinosinusitis[J]. Ear Nose Throat J, 2020, DOI: 10.1177/0145561320968936[Epub ahead of print].
[27]	LA HOZ RM, MORRIS MI, AST Infectious Diseases Community of Practice. Intestinal parasites including cryptosporidium, cyclospora, giardia, and microsporidia, entamoeba histolytica, strongyloides, schistosomiasis, and echinococcus: guidelines from the american society of transplantation infectious diseases community of practice[J]. Clin Transplant, 2019, 33(9): e13618. DOI: 10.1111/ctr.13618.
[28]	JASNI N, SAIDIN S, ARIFIN N, et al. A review: natural and synthetic compounds targeting entamoeba histolytica and its biological membrane[J]. Membranes (Basel), 2022, 12(4): 396. DOI: 10.3390/membranes12040396.
[29]	GOEL V, JAIN A, SHARMA G, et al. Evaluating the efficacy of nitazoxanide in uncomplicated amebic liver abscess[J]. Indian J Gastroenterol, 2021, 40(3): 272-280. DOI: 10.1007/s12664-020-01132-w.
[30]	GOULD LH, KLINE J, MONAHAN C, et al. Outbreaks of disease associated with food imported into the United States, 1996-2014[J]. Emerg Infect Dis, 2017, 23(3): 525-528. DOI: 10.3201/eid2303.161462.
[31]	CAMARGO LFA, KAMAR N, GOTUZZO E, et al. Schistosomiasis and strongyloidiasis recommendations for solid-organ transplant recipients and donors[J]. Transplantation, 2018, 102(2S Suppl 2): S27-S34. DOI: 10.1097/TP.0000000000002016.
[32]	谢金玲, 余德基, 刘国安, 等. 粪类圆线虫和华支睾吸虫合并感染1例并文献复习[J]. 中国感染控制杂志, 2022, 21(1): 92-96. DOI: 10.12138/j.issn.1671-9638.20221798. XIE JL, YU DJ, LIU GA, et al. Co-infection of strongyloides stercoralis and clonorchis sinensis: one case report and literature review[J]. Chin J Infect Control, 2022, 21(1): 92-96. DOI: 10.12138/j.issn.1671-9638.20221798.
[33]	EL MOGHAZY W, KASHKOUSH S, O'HALI W, et al. Long-term outcome after liver transplantation for hepatic schistosomiasis: a single-center experience over 15 years[J]. Liver Transpl, 2015, 21(1): 96-100. DOI: 10.1002/lt.24010.
[34]	KAYLER LK, RUDICH SM, MERION RM. Orthotopic liver transplantation from a donor with a history of schistosomiasis[J]. Transplant Proc, 2003, 35(8): 2974-2976. DOI: 10.1016/j.transproceed.2003.10.065.
[35]	格桑卓嘎, 汤晓佳, 王政和, 等. 2017年拉萨地区人群棘球蚴病流行现状与特征[J]. 中国寄生虫学与寄生虫病杂志, 2020, 38(1): 36-40. DOI: 10.12140/j.issn.1000-7423.2020.01.006. GESANG ZG, TANG XJ, WANG ZH, et al. Prevalence and transmission characteristics of human echinococcosis in Lhasa area, China, in 2017[J]. Chin J Parasitol Parasit Dis, 2020, 38(1): 36-40. DOI: 10.12140/j.issn.1000-7423.2020.01.006.
[36]	ALIAKBARIAN M, TOHIDINEZHAD F, ESLAMI S, et al. Liver transplantation for hepatic alveolar echinococcosis: literature review and three new cases[J]. Infect Dis (Lond), 2018, 50(6): 452-459. DOI: 10.1080/23744235.2018.1428823.

Relative Articles

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Figures(1)

Get Citation

PDF

XML

Article Metrics

Article views (382) PDF downloads(103)

Organ transplantation and parasitic infection

doi: 10.3969/j.issn.1674-7445.2022.04.005

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Organ transplantation and parasitic infection

doi: 10.3969/j.issn.1674-7445.2022.04.005

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Export File

Citation

Format

Content